JWM
AXSM icon

JPL Wealth Management’s Axsome Therapeutics AXSM Stock Holding History

JPL Wealth Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Buy
+76
New +$13.1K ﹤0.01% 480
2025
Q4 		– Sell
-76
Closed -$9.23K – 203
2025
Q3 		$9.23K Buy
+76
New +$8.56K ﹤0.01% 557

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JPL Wealth Management's AXSM Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Axsome Therapeutics (AXSM) in Q1 2026: 76 shares worth $12.8K. The stake represents ﹤0.01% of the portfolio and ranks #480 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in AXSM as recently as Q3 2025.

JPL Wealth Management first reported a position in AXSM in Q3 2025 and has held it in 2 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • JPL Wealth Management held 76 shares of Axsome Therapeutics worth $12.8K as of Q1 2026.
  • Axsome Therapeutics was a new JPL Wealth Management position in Q1 2026.
  • Axsome Therapeutics made up ﹤0.01% of JPL Wealth Management's portfolio in Q1 2026, its #480 holding.
  • JPL Wealth Management first reported a position in Axsome Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.